Tag: LIXTE Biotechnology

LIXTE Biotechnology commences Phase 1b/2 clinical trial in ovarian cancer

businessnewstoday- January 29, 2024 0

LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) has initiated a pivotal Phase 1b/2 clinical trial, in partnership with GSK, to evaluate the potential of ... Read More